PredOmix, Core Diagnostics partner to launch OncoVeryx-F
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Product deliveries scheduled in Q3 of 2023
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Subscribe To Our Newsletter & Stay Updated